세계의 급성 척수 손상 시장 보고서(2025년)

An acute spinal cord injury (SCI) is a traumatic condition characterized by the potential occurrence of a spinal cord contusion (bruising), partial tearing, or complete transection (full severance) resulting from a traumatic event. Such injuries can lead to a significant reduction or complete loss of mobility, sensory perception, and organ function below the point of injury. Acute spinal cord injuries tend to be more prevalent among males and young adults, with causes ranging from motor vehicle accidents, falls, sports-related incidents, to complications arising from surgical procedures.

The primary categories of acute spinal cord injuries are complete and incomplete injuries. A complete spinal cord injury signifies the total absence of sensory and motor capabilities below the level of the injury. Medical professionals typically employ laboratory tests and various imaging procedures within hospital and clinical settings to diagnose these injuries.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The acute spinal cord injury market research report is one of a series of new reports from The Business Research Company that provides acute spinal cord injury market statistics, including acute spinal cord injury industry global market size, regional shares, competitors with a acute spinal cord injury market share, detailed acute spinal cord injury market segments, market trends and opportunities and any further data you may need to thrive in the acute spinal cord injury industry. This acute spinal cord injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute spinal cord injury market size has grown strongly in recent years. It will grow from $6.7 billion in 2024 to $7.06 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising incidence of acute spinal cord injuries, increasing awareness of acute spinal cord injury's and their treatment options, growing demand for personalized care, rising disposable income levels, increasing government spending on asci research and development.

The acute spinal cord injury market size is expected to see strong growth in the next few years. It will grow to $8.79 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to emerging therapies, telemedicine adoption, patient-centric care models, increasing focus on preventive healthcare and injury prevention. Major trends in the forecast period include medical advancements, rehabilitation techniques, neuroprotection therapies, psychosocial support, advocacy and accessibility.

The forecast of 5.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of robotic exoskeletons and neurostimulation implants sourced from Japan and Canada, thereby slowing recovery timelines and elevating long-term care expenses for spinal trauma patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing number of road accidents is expected to drive the growth of the acute spinal cord injury market in the coming years. A road accident involves the collision of a motor vehicle, leading to injury or potentially fatal consequences. Spinal cord injuries resulting from accidents can affect the central nervous system (CNS), disrupting the nerves essential for movement and sensory functions. The force of the impact during an accident can cause trauma to the cervical, lumbar, or thoracic spine, leading to damage or severing of the spinal cord, which may result in paralysis. For example, in June 2024, according to the Welsh Government, a government body in Wales, police reported a total of 4,348 road casualties in 2023, marking a 2% increase from 2022. Therefore, the rise in road accidents is contributing to the growth of the acute spinal cord injury market.

The growing number of clinical trials is expected to drive the expansion of the acute spinal cord injury market. Clinical trials play a vital role in advancing our knowledge and treatment options for Acute Spinal Cord Injury (SCI). These trials systematically investigate new therapies, treatments, or interventions to evaluate their safety and effectiveness in SCI patients. For example, as of May 17, 2023, ClinicalTrials.gov reported 452,604 globally registered clinical studies, with 64,838 actively seeking participants. This represents a significant increase from the approximately 365,000 registered trials in early 2021. Hence, the increasing number of clinical trials is a key factor fueling the growth of the acute spinal cord injury market.

Prominent companies operating in this space are dedicated to creating innovative medications to better serve their patients and maintain their market positions. The development of novel drugs, such as LYVISPAH, has the potential to improve treatment outcomes, particularly through combination therapy. For instance, in July 2022, Amneal Pharmaceuticals, a US-based pharmaceutical firm, introduced LYVISPAH, an FDA-approved baclofen oral granule available in 5 mg, 10 mg, and 20 mg doses. LYVISPAH is designed to treat spasticity associated with multiple sclerosis and other spinal cord disorders, addressing issues like flexor spasms, related pain, muscle rigidity, and spasticity. It offers flexible dosing options and is bioequivalent to oral baclofen tablets, potentially benefiting patients with spinal cord injuries and related conditions.

In February 2023, Globus Medical Inc., a US-based company specializing in musculoskeletal device solutions, completed the acquisition of NuVasive Inc. for $3.1 billion. This strategic move empowered Globus Medical to strengthen and expand its portfolio in musculoskeletal disorder devices, positioning it as a leading company in musculoskeletal technology. NuVasive Inc. is a US-based firm known for its development of medical devices and procedures for minimally invasive spinal cord surgery.

Major companies operating in the acute spinal cord injury market are Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Stanford Health Care, BioMarin Pharmaceutical Inc., Neuralstem Inc., Kennedy Krieger Institute, Acorda Therapeutics Inc., Craig Hospital, Omeros Corporation, Lineage Cell Therapeutics Inc., Pharmazz Inc., Asterias Biotherapeutics Inc., Histocell S.L., Athersys Inc., ReNetX Bio, Kringle Pharma Inc., BioArctic AB, BioAxone BioSciences Inc., InVivo Therapeutics Holdings Corp, Geron Corporation, Neuronax SA, Tenax Therapeutics, Eusol Biotech Co. Ltd.

North America was the largest region in the acute spinal cord injury market in 2024. The regions covered in acute spinal cord injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute spinal cord injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute spinal cord injury market include revenues earned through entities by types such as complete spinal cord injury and incomplete spinal cord injury. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Spinal Cord Injury Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute spinal cord injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute spinal cord injury ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute spinal cord injury market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Complete Spinal Cord Injury; Incomplete Spinal Cord Injury
• 2) By Diagnosis Type: Laboratory Tests; Imaging Tests
• 3) By Application: Hospitals; Clinics
• Subsegments:
• 1) By Complete Spinal Cord Injury: Tetraplegia; Paraplegia
• 2) By Incomplete Spinal Cord Injury: Central Cord Syndrome; Anterior Cord Syndrome; Brown-Sequard Syndrome; Conus Medullaris Syndrome; Cauda Equina Syndrome
• Companies Mentioned: Pfizer Inc; AbbVie Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Biogen Inc.; Vertex Pharmaceuticals Inc; Mitsubishi Tanabe Pharma Corporation; Stanford Health Care; BioMarin Pharmaceutical Inc.; Neuralstem Inc; Kennedy Krieger Institute; Acorda Therapeutics Inc; Craig Hospital; Omeros Corporation; Lineage Cell Therapeutics Inc; Pharmazz Inc.; Asterias Biotherapeutics Inc; Histocell S.L.; Athersys Inc.; ReNetX Bio; Kringle Pharma Inc; BioArctic AB; BioAxone BioSciences Inc.; InVivo Therapeutics Holdings Corp; Geron Corporation; Neuronax SA; Tenax Therapeutics; Eusol Biotech Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Spinal Cord Injury Market Characteristics

3. Acute Spinal Cord Injury Market Trends And Strategies

4. Acute Spinal Cord Injury Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Acute Spinal Cord Injury Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acute Spinal Cord Injury PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acute Spinal Cord Injury Market Growth Rate Analysis
• 5.4. Global Acute Spinal Cord Injury Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acute Spinal Cord Injury Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acute Spinal Cord Injury Total Addressable Market (TAM)

6. Acute Spinal Cord Injury Market Segmentation

• 6.1. Global Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Spinal Cord Injury
• Incomplete Spinal Cord Injury
• 6.2. Global Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Tests
• Imaging Tests
• 6.3. Global Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• 6.4. Global Acute Spinal Cord Injury Market, Sub-Segmentation Of Complete Spinal Cord Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tetraplegia
• Paraplegia
• 6.5. Global Acute Spinal Cord Injury Market, Sub-Segmentation Of Incomplete Spinal Cord Injury, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Central Cord Syndrome
• Anterior Cord Syndrome
• Brown-Sequard Syndrome
• Conus Medullaris Syndrome
• Cauda Equina Syndrome

7. Acute Spinal Cord Injury Market Regional And Country Analysis

• 7.1. Global Acute Spinal Cord Injury Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acute Spinal Cord Injury Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Spinal Cord Injury Market

• 8.1. Asia-Pacific Acute Spinal Cord Injury Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Spinal Cord Injury Market

• 9.1. China Acute Spinal Cord Injury Market Overview
• 9.2. China Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Spinal Cord Injury Market

• 10.1. India Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Spinal Cord Injury Market

• 11.1. Japan Acute Spinal Cord Injury Market Overview
• 11.2. Japan Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Spinal Cord Injury Market

• 12.1. Australia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Spinal Cord Injury Market

• 13.1. Indonesia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Spinal Cord Injury Market

• 14.1. South Korea Acute Spinal Cord Injury Market Overview
• 14.2. South Korea Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Spinal Cord Injury Market

• 15.1. Western Europe Acute Spinal Cord Injury Market Overview
• 15.2. Western Europe Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Spinal Cord Injury Market

• 16.1. UK Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Spinal Cord Injury Market

• 17.1. Germany Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Spinal Cord Injury Market

• 18.1. France Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Spinal Cord Injury Market

• 19.1. Italy Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Spinal Cord Injury Market

• 20.1. Spain Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Spinal Cord Injury Market

• 21.1. Eastern Europe Acute Spinal Cord Injury Market Overview
• 21.2. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Spinal Cord Injury Market

• 22.1. Russia Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Spinal Cord Injury Market

• 23.1. North America Acute Spinal Cord Injury Market Overview
• 23.2. North America Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Spinal Cord Injury Market

• 24.1. USA Acute Spinal Cord Injury Market Overview
• 24.2. USA Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Spinal Cord Injury Market

• 25.1. Canada Acute Spinal Cord Injury Market Overview
• 25.2. Canada Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Spinal Cord Injury Market

• 26.1. South America Acute Spinal Cord Injury Market Overview
• 26.2. South America Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Spinal Cord Injury Market

• 27.1. Brazil Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Spinal Cord Injury Market

• 28.1. Middle East Acute Spinal Cord Injury Market Overview
• 28.2. Middle East Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Spinal Cord Injury Market

• 29.1. Africa Acute Spinal Cord Injury Market Overview
• 29.2. Africa Acute Spinal Cord Injury Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acute Spinal Cord Injury Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acute Spinal Cord Injury Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Spinal Cord Injury Market Competitive Landscape And Company Profiles

• 30.1. Acute Spinal Cord Injury Market Competitive Landscape
• 30.2. Acute Spinal Cord Injury Market Company Profiles
  • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Acute Spinal Cord Injury Market Other Major And Innovative Companies

• 31.1. Vertex Pharmaceuticals Inc
• 31.2. Mitsubishi Tanabe Pharma Corporation
• 31.3. Stanford Health Care
• 31.4. BioMarin Pharmaceutical Inc.
• 31.5. Neuralstem Inc
• 31.6. Kennedy Krieger Institute
• 31.7. Acorda Therapeutics Inc
• 31.8. Craig Hospital
• 31.9. Omeros Corporation
• 31.10. Lineage Cell Therapeutics Inc
• 31.11. Pharmazz Inc.
• 31.12. Asterias Biotherapeutics Inc
• 31.13. Histocell S.L.
• 31.14. Athersys Inc.
• 31.15. ReNetX Bio

32. Global Acute Spinal Cord Injury Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Spinal Cord Injury Market

34. Recent Developments In The Acute Spinal Cord Injury Market

35. Acute Spinal Cord Injury Market High Potential Countries, Segments and Strategies

• 35.1 Acute Spinal Cord Injury Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acute Spinal Cord Injury Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acute Spinal Cord Injury Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer